http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102030716-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d94573ab2c57e8b193f3a22accddf9fe
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
filingDate 2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48bd3ac147f8557aa28ae7521b7e270b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5bcf7e1988203e23c2885c7d1c86e38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c38c928fe6e4fb837f97bdb88b57fa
publicationDate 2011-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102030716-A
titleOfInvention Method for preparing gefitinib
abstract The invention discloses a novel preparation method for synthesizing gefitinib. 3,4-dimethoxybenzoic acid (2) is taken as a raw material, and the method comprises the following steps of: nitrifying, demethylating and methylating the 3,4-dimethoxybenzoic acid (2) to prepare an intermediate of 2-nitryl-4-methoxy-5-methyl-hydroxybenzoate (5); reacting the intermediate with 4-(3-bromopropyl) morpholine, and introducing an alkyl side chain to prepare an intermediate 6; reducing nitryl, and performing ring formation with methanamide to construct a quinoline matrix ring 8; halogenating 4-carbonyl by using the compound 8 under the action of thionyl chloride to generate an intermediate 9; and reacting with halogen substituted aromatic amine 3-chloro4-fluoroaniline to obtain the target product of gefitinib (1). In the method, the selected initial raw material is low in cost, the synthesizing route is simplified, and the raw material utilization rate and the total yield are greatly improved. The intermediates obtained in the reactions are mostly purified by a re-crystallization method, or directly subjected to the next reaction, so the yield is high, a few three wastes are generated in the reaction process, the cost is low and the method is favorable for industrial production.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102584720-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102584720-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103910689-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103910689-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103864719-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103524433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110747489-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110747489-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103755648-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103755648-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103319422-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103319422-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105218476-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108727284-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108727284-A
priorityDate 2009-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424545842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19807028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465954366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23132475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413579660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420991979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424465080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164110631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10471217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422418272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135446413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78690

Total number of triples: 43.